A detailed history of Beirne Wealth Consulting Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Beirne Wealth Consulting Services, LLC holds 294 shares of LLY stock, worth $269,892. This represents 0.1% of its overall portfolio holdings.

Number of Shares
294
Previous 586 49.83%
Holding current value
$269,892
Previous $342 Million 33.15%
% of portfolio
0.1%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $172,922 - $231,345
-292 Reduced 49.83%
294 $229 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $307,761 - $362,810
586 New
586 $342 Million
Q2 2019

Jul 25, 2019

SELL
$110.79 - $129.32 $171,613 - $200,316
-1,549 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $172,419 - $202,949
1,549 New
1,549 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $872B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Beirne Wealth Consulting Services, LLC Portfolio

Follow Beirne Wealth Consulting Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.